St Phi Therapeutics
About:
Yizun Biotechnology is a cutting-edge immune cell therapy company that has developed many unique platform technologies.
Website: http://www.stphitherapeutics.com
Top Investors: Shenzhen Capital Group, Tao Capital Partners, Panacea Venture, Tailong Investment, Tasly Capital
Description:
Yizun Biotechnology is a cutting-edge immune cell therapy company that has developed many unique platform technologies, including solid tumor treatment and allogeneic universal cell therapy.
Total Funding Amount:
100M CNY
Headquarters Location:
Shanghai, Shanghai, China
Founded Date:
2017-01-01
Contact Email:
izun(AT)stphibio.com
Founders:
Number of Employees:
Last Funding Date:
2024-04-15
IPO Status:
Private
Industries:
© 2025 bioDAO.ai